Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.64 -0.06 (-8.64%)
As of: Oct 23, 2026 · 1:57 PM EDT

Milestone Pharmaceuticals (MIST) Other Accumulated Expenses (2018 - 2026)

Updated

Milestone Pharmaceuticals' Other Accumulated Expenses came in at $1.2 million for Q2 2026, up 395.1% from $243,000 a year earlier and up 44.2% from the prior quarter.

Analysis

Milestone Pharmaceuticals (MIST) Other Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025, Milestone Pharmaceuticals' Other Accumulated Expenses was $495,000, up 3.1% from FY2024.

  • Other Accumulated Expenses carries a five-year compound annual growth rate of 24.7% (FY2020 to FY2025).
  • Going back by year, Other Accumulated Expenses was $480,000 in FY2024 (+90.5%), $252,000 in FY2023 (-1.2%), $255,000 in FY2022 (-41.6%) and $437,000 in FY2021 (+166.5%).
  • The Q2 2026 figure represents the highest quarterly Other Accumulated Expenses since Q3 2023.
  • Year-over-year, Other Accumulated Expenses has increased for four consecutive quarters, with growth averaging 67.1% over the last eight quarters.
  • The fastest year-over-year change in Other Accumulated Expenses over five years came in Q2 2026 (growth of 395.1%), and the weakest in Q3 2024 (a decline of 70.0%).
  • Business Quant data shows MIST's Other Accumulated Expenses at $834,000 (Q1 2026), $495,000 (Q4 2025) and $518,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,132.13 Bn 1,100.72 Bn 19.71 Bn
2 Johnson & Johnson 634.87 Bn 554.73 Bn 17.30 Bn
3 AbbVie 506.59 Bn 479.70 Bn 12.70 Bn
4 Merck 357.59 Bn 311.97 Bn 12.21 Bn
5 Novartis Ag 291.51 Bn 255.50 Bn 11.24 Bn
6 Astrazeneca 265.00 Bn 238.69 Bn 12.86 Bn
7 Amgen 238.17 Bn 193.57 Bn 7.24 Bn
8 Gilead Sciences 195.18 Bn 169.37 Bn 6.22 Bn
9 Pfizer 171.20 Bn 117.84 Bn 10.94 Bn
10 Milestone Pharmaceuticals 88.76 Mn -81.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.20 Mn
Mar 31, 2026 834,000.00
Dec 31, 2025 495,000.00
Sep 30, 2025 518,000.00
Jun 30, 2025 243,000.00
Mar 31, 2025 379,000.00
Dec 31, 2024 480,000.00
Sep 30, 2024 376,000.00
Jun 30, 2024 309,000.00
Mar 31, 2024 466,000.00
Dec 31, 2023 252,000.00
Sep 30, 2023 1.25 Mn
Jun 30, 2023 637,000.00
Mar 31, 2023 546,000.00
Dec 31, 2022 255,000.00
Sep 30, 2022 760,000.00
Jun 30, 2022 1.09 Mn
Mar 31, 2022 392,000.00
Dec 31, 2021 437,000.00
Sep 30, 2021 339,000.00
API Access

Milestone Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MIST&period=max&api_key=YOUR_API_KEY